Tuesday, November 24, 2009, 3:50am EST - Canadian Markets open in 5 hours and 40 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Integra LifeSciences Holdings Corporation (IART)

 On Nov 23: 32.51 USD   0.00 (0.00%)  
MORE ON IART
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Integra LifeSciences Holdings C (NasdaqNM:IART) Delayed quote dataEdit
Last Trade: 32.51 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 32.51
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 35.06
Day's Range: N/A - N/A
52wk Range: 18.97 - 37.40
Volume: 0
Avg Vol (3m): 145,234
Market Cap: 925.88M
P/E (ttm): 14.64
EPS (ttm): 2.22
Div & Yield: N/A (N/A%)
Integra LifeSciences Holdings Corporation (IART)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add IART to Portfolio   Download Data

HEADLINES
• CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
at Seeking Alpha (Thu, Nov 19)
• INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Other Events
EDGAR Online (Mon, Nov 16)
• INTEGRA LIFESCIENCES HOLDINGS CORP Financials
EDGAR Online Financials (Sat, Nov 7)
• New Star Analyst Rankings for Integra LifeSciences Holdings C
StarMine (Thu, Nov 5)
• Earnings roundup: Time Warner, Garmin
AP (Wed, Nov 4)
• Integra swings to 3Q profit on lower expenses
AP (Wed, Nov 4)
• Q3 2009 Integra LifeSciences Corporation Earnings Release - Before Market Open
CCBN (Wed, Nov 4)
• INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD D
EDGAR Online (Wed, Nov 4)
• INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
• INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea
EDGAR Online (Tue, Nov 3)
• Integra Launches New Product
Zacks.com (Thu, Oct 1)
• Piper Jaffray Orthopedic Medical Device Equity Analyst Picks Stock Winners In Beaten Up Market
Wall Street Transcript (Fri, Sep 25)
More Headlines for IART...
ANALYST
EPS Est (next year) (Dec-09) : 2.10
EPS Est (in 2 years) (Dec-10) : 2.34
Avg Rec (current)*: 2.5
PEG Ratio: 1.11
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery in the United States and internationally.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices